HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
CEO: Robert Eno. Company website
HeartBeam, Inc. (BEAT) trades at $0.82, down 31.68% on the day, as of Sep 20, 2026 15:00 UTC.
HeartBeam, Inc. has a market capitalisation of $28.24M, calculated from the live BEAT share price and shares outstanding.
BEAT has no meaningful price-to-earnings ratio: HeartBeam, Inc. lost $0.63 per share over the last twelve months, and a P/E is only defined on positive earnings.
HeartBeam, Inc. generated revenue of $0.00 over the trailing twelve months.
BEAT has traded between $0.80 and $1.78 over the past 52 weeks, and the last price is 53.9% below that high.
Yes. HeartBeam, Inc. keeps 0.00% of revenue as net income over the trailing twelve months.
Wall Street analysts rate BEAT Buy, with an average price target of $5.00, 509.9% above the current price.
HeartBeam, Inc. is classified under the Healthcare sector and the Medical - Healthcare Information Services industry, and is domiciled in US .
Robert Eno is the chief executive of HeartBeam, Inc., which employs 21 people.
QFI Terminal shows BEAT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open BEAT in Terminal See plans